Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Hum Mutat. 2019 Sep 10;40(12):2393–2413. doi: 10.1002/humu.23895

Table 2.

Enrichment of patient-ascertained pathogenic-reported genetic variation in M2 pore loop in GRIN1, GRIN2A, and GRIN2B

M2 region missense (subset of total)
Total missense
P-value*
Residues gnomAD Disease gnomAD Disease
GRIN1 D599-E621 0 2 171 15 0.0061
GRIN2A G596-V619 3 3 645 18 0.0003
GRIN2B G597-V620 1 7 442 23 2.1×10−9
*

Fisher’s exact test, αcorrected = .016

gnomAD data based on release 2.1 (excluding filtered out variants). GRIN1 = NP_015566, GRIN2A = NP_000824 and GRIN2B = NP_000825. The total disease-related missense variants were from missense de novo variants in Swanger 2016, and were topped up with additionally published mutations since then adopting the same criteria(Swanger et al., 2016).